D.A. Davidson & Co. Anixa Biosciences Inc Transaction History
D.A. Davidson & Co.
- $11.2 Billion
- Q2 2024
A detailed history of D.A. Davidson & Co. transactions in Anixa Biosciences Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 736,415 shares of ANIX stock, worth $2.64 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
736,415Holding current value
$2.64 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ANIX
# of Institutions
56Shares Held
5.54MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.39MShares$5 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC604KShares$2.17 Million0.19% of portfolio
-
Ubs Group Ag531KShares$1.9 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.83 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA331KShares$1.19 Million0.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $110M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...